-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology qPCR Platform: Features and Benefits
Author:
InnoModels
Release time:
2024-07-02
In the field of oncology drug discovery and development, an efficient and precise technology platform is crucial to accelerate drug development, optimize drug effects and ensure drug safety. With its unique qPCR platform, InnoModels Biotechnology (Beijing) Co., Ltd. provides powerful technical support for oncology drug discovery and development, demonstrating significant advantages.
1、High sensitivity and precision
InnoModels' qPCR platform is known for its high sensitivity and accuracy. It uses real-time quantitative polymerase chain reaction (qPCR) technology, which is capable of detecting extremely low levels of target nucleic acids and providing accurate quantitative data. This is critical for assessing the impact of tumor drugs on the expression of target genes and helps researchers to more accurately evaluate the activity and effect of drugs.
2、Optimized design and high throughput
For the characteristics of nucleic acid coupled drugs and mRNA drugs, the qPCR platform of InnoModels Biotechnology has been specially designed. This optimization ensures high efficiency and specificity of the assay, providing researchers with reliable experimental data. At the same time, the platform supports simultaneous detection of multiple samples, which greatly improves experimental efficiency and accelerates the drug development process.
3、Flexibility and customization
InnoModels Bio's qPCR platform is highly flexible and can be customized according to the needs of different researchers. Whether it is selecting specific probes, adjusting experimental conditions or designing personalized experimental protocols, the platform can meet the needs of researchers. This flexibility enables the platform to better adapt to the needs of different oncology drug development projects and provide comprehensive support for researchers.

4、Cutting-edge technology and expert team
InnoModels Bio's qPCR platform adopts the latest qPCR technology to ensure that researchers can obtain the best experimental results. Meanwhile, the company has a team of experts composed of experienced scientists, who not only have profound professional knowledge, but also have rich experimental experience. They can provide strong technical support for researchers to ensure the success of experiments.
5、One-stop service and support
From sample processing to data analysis, InnoModels Biotechnology provides one-stop service for researchers. They not only provide all the reagents and consumables needed for the experiment, but also take care of the sample processing and analysis. Researchers only need to provide their experimental needs and data requirements, and the company can provide them with a complete experimental solution. This all-round support enables researchers to focus more on the core work of drug development and improves R&D efficiency.
6、Wide application and high reliability
InnoModels Bio's qPCR platform is not only suitable for oncology drug discovery and development, but also widely used in gene expression analysis, pathogen detection, genetic disease diagnosis and other fields. Its high reliability and robustness have been confirmed by several studies. This extensive application background makes the platform have higher recognition and trust in the field of oncology drug development.
In summary, the qPCR platform of InnoModels Biotechnology provides powerful technical support in the field of oncology drug discovery and development with its advantages of high sensitivity and accuracy, optimized design and high throughput, flexibility and customized service, cutting-edge technology and expert team, as well as one-stop service and support. It is believed that in the future, InnoModels' qPCR platform will continue to play its important role in promoting the progress and development of oncology drug discovery and development.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd